These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 1379906)

  • 1. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
    Dodwell DJ; de Campos ES; Radford JA
    Drugs; 1992 Jul; 44(1):1-8. PubMed ID: 1379906
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of malignant lymphomas].
    Luporini G
    Radiol Med; 1976; 62(7-8):553-7. PubMed ID: 95671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of Hodgkin's disease.
    Carde P
    Nouv Rev Fr Hematol (1978); 1990; 32(2):169-73. PubMed ID: 1696000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
    J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
    Gisselbrecht C; Lepage E; Brice P; Trédaniel J; Gerota I
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):131-4. PubMed ID: 2455276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hematologic tumors].
    Ogawa M
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1416-21. PubMed ID: 14584273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Hehn ST; Miller TP
    Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K; Honda T; Hattori M
    Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy in Hodgkin's disease.
    Kumari PK; Chellam VG; Madhavan J; Ratheesan K; Pillai GR; Kumar SR; Nair MK
    Indian Pediatr; 1996 Jul; 33(7):561-5. PubMed ID: 8979565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
    Płuzańska A; Berner J; Kowalczyński M; Dowgier-Witczak I; Chmielowska E; Woźniak L
    Pol Arch Med Wewn; 1986 May; 75(5):344-50. PubMed ID: 2431397
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 13. ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
    Oncology (Williston Park); 1996 Apr; 10(4):593-4. PubMed ID: 8723294
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent progress in the chemotherapy of malignant lymphoma].
    Tobinai K
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):437-43. PubMed ID: 7887635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
    Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
    Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.
    Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447
    [No Abstract]   [Full Text] [Related]  

  • 19. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
    Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L
    Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent issues in chemotherapy for Hodgkin's disease.
    Canellos GP
    Curr Opin Oncol; 1989 Oct; 1(1):29-31. PubMed ID: 2489946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.